Q3 2019 Dynavax Technologies Corp Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Dynavax Technologies Third Quarter 2019 Conference Call. As a reminder, this conference call is being recorded. (Operator Instructions)
I'd now like to turn the call over to Nicole Arndt, Senior Manager, Investor Relations. You may begin.
Thank you, James. Good afternoon. Welcome to the Dynavax Third Quarter 2019 Financial Results and Corporate Update Conference Call.
With me today are Ryan Spencer, Co-President; and Michael Ostrach, Chief Financial Officer.
Before we begin, I advise you that we will be making forward-looking statements today, including statements regarding HEPLISAV-B's commercial profile, revenue expectations, potential peak revenue and the completion of post-marketing studies. These statements are subject to a number of risks and uncertainties that could cause actual results to differ materially. These risks are summarized in today's press release and are detailed in the Risk Factors section of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
